HomeORKA • NASDAQ
add
Oruka Therapeutics Inc
Previous close
$27.83
Day range
$27.79 - $30.27
Year range
$5.49 - $31.00
Market cap
1.43B USD
Avg Volume
403.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 34.10M | 15.81% |
Net income | -30.28M | -5.78% |
Net profit margin | — | — |
Earnings per share | -0.55 | 62.33% |
EBITDA | -34.08M | -15.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 349.16M | -15.02% |
Total assets | 509.25M | 22.98% |
Total liabilities | 22.46M | 18.96% |
Total equity | 486.79M | — |
Shares outstanding | 48.41M | — |
Price to book | 2.78 | — |
Return on assets | -19.68% | — |
Return on capital | -20.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -30.28M | -5.78% |
Cash from operations | -21.60M | 22.35% |
Cash from investing | -122.45M | -71,507.60% |
Cash from financing | 169.91M | -59.90% |
Net change in cash | 25.86M | -93.47% |
Free cash flow | -4.53M | 61.12% |
About
Founded
2024
Headquarters
Website
Employees
28
